For people living with type 1 diabetes (T1D), achieving financial independence can be particularly daunting given the high costs of insulin and other diabetes supplies and, in the United States, an employment-based insurance model with minimal safety net (3). This evidence concerns the gene INS and type 1 diabetes mellitus.